SomaGenics’ sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus

SANTA CRUZ, Calif., Sept. 20, 2011 — SomaGenics, Inc., a biotechnology company specializing in RNA-based technologies, presented exciting data on the efficacy of RNA interference (RNAi) therapeutics against Hepatitis C virus (HCV) based on the company’s sshRNA platform.
SomaGenics…

Treatment for Hepatitis C with Antiviral Supplement Gene-Eden, a New Opportunity?

ROCHESTER, N.Y., May 13, 2010 — A new review on the Amazon website suggests that the natural antiviral supplement Gene-Eden may be effective in reducing the Hepatitis C viral load in people infected with the virus.
According to Adrian Di Bisceglie, MD, chair and professor of internal medicine at S…

Hep C Survivor Breaks the Silence on a Growing Epidemic in New Book, ‘Breaking Free from Hepatitis C: A Personal Journey’

Personal account, based on author’s journal and experience over the course of 11 years, offers insider’s look and calls for action on prevention
LACONIA, N.H., Oct. 20, 2009 — In the United States alone, it is estimated that up to four million people carry the Hepatitis C virus. More c…